Patents by Inventor Alexander FARWICK

Alexander FARWICK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230332129
    Abstract: The present invention relates to a temperature optimized L-arabinose isomerase with a high catalytic activity within feedstocks comprising a high concentration of divalent metal ions, a nucleic acid sequence encoding the inventive L-arabinose isomerase, a vector comprising the nucleic acid sequence encoding the inventive L-arabinose isomerase, a composition containing the inventive L-arabinose isomerase, a yeast cell comprising the inventive L- arabinose isomerase, the use of the inventive L-arabinose isomerase, the composition or the yeast cell for the fermentation of feedstock with a high content of divalent metal ions.
    Type: Application
    Filed: March 16, 2020
    Publication date: October 19, 2023
    Inventors: Alexander FARWICK, Jörg CLAREN, Heiko DIETZ, Helge JOCHENS, Magdalena MERTEL
  • Publication number: 20230159941
    Abstract: The present invention comprises a chimeric promoter which initiates the transcription of a gene depending on different conditions such as carbon sources. Further the invention relates to a recombinant DNA fragment comprising the chimeric promoter, an expression plasmid comprising the recombinant DNA fragment and a host cell transformed with the recombinant DNA fragment.
    Type: Application
    Filed: January 13, 2020
    Publication date: May 25, 2023
    Inventors: Heiko DIETZ, Magdalena MERTEL, Jörg CLAREN, Alexander FARWICK
  • Patent number: 10308692
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to M435, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: June 4, 2019
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Eckhard Boles, Alexander Farwick, Ferdinand Kirchner, Virginia Schadeweg, Mislav Oreb
  • Patent number: 10246495
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to T354, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: April 2, 2019
    Assignee: BUTALCO GMBH
    Inventors: Eckhard Boles, Heiko Dietz, Alexander Farwick, Virginia Schadeweg, Mislav Oreb
  • Publication number: 20170334955
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to M435, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Application
    Filed: October 22, 2015
    Publication date: November 23, 2017
    Inventors: Eckhard Boles, Alexander Farwick, Ferdinand Kirchner, Virginia Schadeweg, Mislav Oreb
  • Publication number: 20170283835
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to T354, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Application
    Filed: October 22, 2015
    Publication date: October 5, 2017
    Applicant: BUTALCO GMBH
    Inventors: Eckhard BOLES, Heiko DIETZ, Alexander FARWICK, Virginia SCHADEWEG, Mislav OREB